Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-interval oral poliovirus vaccine schedules in newborns in Pakistan
ACTRN12611000824965Phase 4Withdrawn
- Sponsor
- Aga Khan University
- Start
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of monovalent oral polio vaccine type 1, bivalent oral poliovirus vaccine types 1 and 3 and trivalent oral poliovirus vaccine in poliomyelitis (4 arms), sponsored by Aga Khan University. Primary endpoint: Type 1 poliovirus seroconversion non-inferiority. Planned start Oct 2011; status: withdrawn.
02
Drugs
monovalent oral polio vaccine type 1bivalent oral poliovirus vaccine types 1 and 3trivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12611000824965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000824965.